PT  - JOURNAL ARTICLE
AU  - Nichols, Emma Hitt
ED  - Park, Jeong Bae
TI  - Metabolic Syndrome Elevates Risk of Microalbuminuria despite BP Control
DP  - 2014 Sep 01
TA  - MD Conference Express
PG  - 13--13
VI  - 14
IP  - 18
4099  - http://mdc.sagepub.com/content/14/18/13.1.short
4100  - http://mdc.sagepub.com/content/14/18/13.1.full
AB  - Fimasartan reduced blood pressure (BP) and albumin-creatinine ratio (ACR) in patients with or without metabolic syndrome; however, patients with metabolic syndrome at baseline and 3 months were at a greater risk of elevated ACR at 1 year. This article presents 3-month and 1-year data from a 3-year multicenter study designed to evaluate the effect of early correction of metabolic syndrome on organ damage for patients with hypertension [K-METS]. The design of this study has been published [Kim C et al. Pulse 2013].